Cargando…
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli
There is urgent need to develop novel treatment strategies to reduce antimicrobial resistance. Collateral sensitivity (CS), where resistance to one antimicrobial increases susceptibility to other drugs, might enable selection against resistance during treatment. However, the success of this approach...
Autores principales: | Podnecky, Nicole L., Fredheim, Elizabeth G. A., Kloos, Julia, Sørum, Vidar, Primicerio, Raul, Roberts, Adam P., Rozen, Daniel E., Samuelsen, Ørjan, Johnsen, Pål J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131505/ https://www.ncbi.nlm.nih.gov/pubmed/30202004 http://dx.doi.org/10.1038/s41467-018-06143-y |
Ejemplares similares
-
Evolutionary Instability of Collateral Susceptibility Networks in Ciprofloxacin-Resistant Clinical Escherichia coli Strains
por: Sørum, Vidar, et al.
Publicado: (2022) -
Host dependent maintenance of a bla(NDM-1)-encoding plasmid in clinical Escherichia coli isolates
por: Gama, João Alves, et al.
Publicado: (2020) -
Evolution of β-lactamase-mediated cefiderocol resistance
por: Fröhlich, Christopher, et al.
Publicado: (2022) -
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
por: Fröhlich, Christopher, et al.
Publicado: (2019) -
O03 The effect of antibiotic selection on collateral susceptibility and evolvability of uropathogenic Escherichia coli
por: Hubbard, Alasdair T M, et al.
Publicado: (2023)